Latest News and Press Releases

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27

GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test

"Know Your Risk" Event a remarkable success in Pasadena.

Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Viral Vector Collaboration and...

Genetic Technologies and 'Wellworks for You' sign B2B sales and marketing deal covering 750 employer groups and 2 million U.S. employees

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "AAV vectors in gene therapy - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "AAV vectors in gene...

New York, April 17, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and Friedreich’s Ataxia Research Alliance (FARA) announced today a collaborative grant for $300,000 awarded to...

GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year

Genetic Technologies to pilot GeneType in Breast Screen centers across the U.S.